Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This trial is going to evaluate the efficacy and safety of IMRT / nab-TP chemotherapy for
unresectable esophageal cancer, and to investigate the optimal concurrent chemotherapy
regimen for local advanced and unresectable esophageal cancer patients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital